Osawa Takahiro, Shinohara Nobuo, Maruyama Satoru, Oba Koji, Abe Takashige, Maru Shintaro, Takada Norikata, Sazawa Ataru, Nonomura Katsuya
Department of Urology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Urol J. 2013 Winter;10(1):784-9.
To evaluate postoperative renal function and risk factors for the loss of renal function in patients who had undergone radical cystectomy.
A retrospective single institutional study evaluated 70 patients, including 54 men and 16 women who underwent radical cystectomy. The median follow-up period was 34.5 months (range, 12 to 228 months). In this cohort, four types of urinary diversions were studied, including ileal neobladder (n = 24), ileocecal neobladder (n = 12), ileal conduit (n = 25), and cutaneous ureterostomy (n = 9). Postoperative changes in renal function were reviewed, and the estimated serum creatinine-based glomerular filtration rate (eGFR) was calculated. The variables analyzed were age, a prior history of hypertension or diabetes mellitus, pre-operative renal function, type of urinary diversion, the postoperative occurrence of acute pyelonephritis, and the presence of chemotherapy.
The mean eGFR was 74.6 (range, 15.2 to 155.1) mL/min/1.73 m² before surgery and 63.6 (range, 8.7 to 111.5) mL/min/1.73 m² at the last follow-up. The 10-year renal deterioration-free interval was 63.8%. Multivariate analysis showed that a postoperative episode of acute pyelonephritis [Odds Ratio (OR), 3.21; 95% Confidence Interval (CI), 1.14 to 9.02; P = .03] and the presence of chemotherapy (OR, 3.27; 95% CI, 1.33 to 8.01; P = .01) were significant adverse factors.
Twenty-four (34.2%) patients demonstrated reduced renal function during the follow-up period. Postoperative episodes of acute pyelonephritis and the presence of chemotherapy were found to be significant adverse factors.
评估接受根治性膀胱切除术患者的术后肾功能及肾功能丧失的危险因素。
一项回顾性单机构研究评估了70例患者,其中包括54例男性和16例女性接受了根治性膀胱切除术。中位随访期为34.5个月(范围12至228个月)。在该队列中,研究了四种尿流改道类型,包括回肠新膀胱(n = 24)、回盲部新膀胱(n = 12)、回肠导管(n = 25)和皮肤输尿管造口术(n = 9)。回顾了术后肾功能的变化,并计算了基于血清肌酐估算的肾小球滤过率(eGFR)。分析的变量包括年龄、高血压或糖尿病病史、术前肾功能、尿流改道类型、术后急性肾盂肾炎的发生情况以及化疗情况。
术前平均eGFR为74.6(范围15.2至155.1)mL/min/1.73 m²,末次随访时为63.6(范围8.7至111.5)mL/min/1.73 m²。10年无肾功能恶化间隔为63.8%。多因素分析显示,术后急性肾盂肾炎发作[比值比(OR),3.21;95%置信区间(CI),1.14至9.02;P = .03]和化疗情况(OR,3.27;95%CI,1.33至8.01;P = .01)是显著的不利因素。
24例(34.2%)患者在随访期间肾功能下降。术后急性肾盂肾炎发作和化疗情况是显著的不利因素。